Top compounds associated with response to AURKA


Feature Type Standardized
Nominal ANOVA
mRNA barasertib CTRPv2 pan-cancer AAC -0.15 7e-06
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.15 9e-06
mRNA TPCA-1 CTRPv2 pan-cancer AAC -0.15 9e-06
mRNA Ispinesib Mesylate GDSC1000 pan-cancer AAC -0.14 1e-05
mRNA indisulam CTRPv2 pan-cancer AAC -0.14 1e-05
mRNA CCT036477 CTRPv2 pan-cancer AAC -0.15 1e-05
mRNA HLI 373 CTRPv2 pan-cancer AAC -0.16 1e-05
mRNA BRD-A94377914 CTRPv2 pan-cancer AAC -0.2 1e-05
mRNA prochlorperazine CTRPv2 pan-cancer AAC -0.16 1e-05
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.15 2e-05
Download CSV